iana-lumab

ianalumab · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iana-lumab, covering 2026-06-03 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) [Phase 3]

See pricing